SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 100 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $960,000 | -72.3% | 97,964 | -69.4% | 0.00% | -66.7% |
| Q4 2016 | $3,460,000 | -30.2% | 320,420 | -33.8% | 0.01% | -40.0% |
| Q3 2016 | $4,960,000 | -68.9% | 483,988 | -60.4% | 0.01% | -69.7% |
| Q2 2016 | $15,957,000 | +63.9% | 1,221,857 | +38.1% | 0.03% | +65.0% |
| Q1 2016 | $9,733,000 | +42.6% | 884,846 | +19.3% | 0.02% | +33.3% |
| Q4 2015 | $6,823,000 | -39.7% | 741,633 | -54.5% | 0.02% | -40.0% |
| Q3 2015 | $11,312,000 | -29.5% | 1,630,093 | -0.2% | 0.02% | -24.2% |
| Q2 2015 | $16,036,000 | -0.8% | 1,633,078 | -10.5% | 0.03% | -2.9% |
| Q1 2015 | $16,169,000 | +0.7% | 1,824,999 | -0.4% | 0.03% | +3.0% |
| Q4 2014 | $16,049,000 | -0.9% | 1,832,181 | -22.0% | 0.03% | -5.7% |
| Q3 2014 | $16,187,000 | +23.3% | 2,349,393 | -5.9% | 0.04% | +20.7% |
| Q2 2014 | $13,126,000 | +12.9% | 2,495,487 | -2.3% | 0.03% | +7.4% |
| Q1 2014 | $11,623,000 | -12.3% | 2,554,593 | -2.9% | 0.03% | -12.9% |
| Q4 2013 | $13,260,000 | -2.8% | 2,631,035 | -2.3% | 0.03% | -11.4% |
| Q3 2013 | $13,648,000 | -3.1% | 2,691,961 | -5.2% | 0.04% | -7.9% |
| Q2 2013 | $14,079,000 | – | 2,838,665 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|